StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMJun 25, 2026, 04:31 PM

Cellectis Shareholders Adopt 29 Resolutions at General Meeting

AI Summary

Cellectis held its shareholders general meeting on June 25, 2026, where approximately 55.84% of voting rights were exercised. Shareholders adopted resolutions 1 through 29 and rejected resolution 30. All voting results were consistent with the recommendations provided by the company's board of directors.

Key Highlights

  • Shareholders general meeting held on June 25, 2026, in Paris, France.
  • Approximately 55.84% of voting rights were exercised at the meeting.
  • Resolutions 1 through 29 were adopted by shareholders.
  • Resolution 30 was rejected by shareholders.
  • All voting outcomes were consistent with the board of directors' recommendations.